FORM 3A - Director/Chief Executive Notice - Interests in Shares of Listed Corporation
 
Form Serial Number: DA20221104E00280
1. Date of relevant event: 03/11/2022
(dd/mm/yyyy)
2. Date when director became aware of the relevant event/ interest in the shares (if later):
(dd/mm/yyyy)
3. Stock code: 03759
4. Name of listed corporation: Pharmaron Beijing Co., Ltd. 
5. Class of shares: A Shares 
6. Number of issued shares in class: 990,042,879
7. Name of director (English) as printed on HKID Card/Passport:
(Surname) Lou
(Other names) Boliang
10. Name of director (Chinese): 樓柏良 
11. Chinese Character Code as printed on HKID Card:
 
24. Details of relevant event:
  Brief description of relevant event Capacity in which shares were/are held Number of shares bought/sold or involved Currency of transaction On Exchange Off Exchange
Before relevant event After relevant event Highest price (per share) Average price (per share) Average consideration (per share) Consideration code
Long position 
1201The number of shares in which you are interested has reduced because:
you completed a sale of the shares
 
2501Other (you must describe the capacity in the Supplementary Information box)
 
 		 349,500  CNY  60.8800  60.3764   
 
Short position 
 
 
 		            
 
25. Total shares in listed corporation immediately before the relevant event:
 Total number of sharesPercentage figure (%)
Long position269,639,94227.24
 
26. Total shares in listed corporation immediately after the relevant event:
 Total number of sharesPercentage figure (%)
Long position269,239,94227.19
 
27. Capacity in which interests disclosed in Box 26 are held:
Code describing capacityNumber of shares
2201Interest of corporation controlled by you
Long position136,048,900
2501Other (you must describe the capacity in the Supplementary Information box)
Long position133,191,042
 
28. Further information in derivative interests in listed corporation :
Derivatives code Exercise period (dd/mm/yyyy) Consideration - if derivatives granted by listed corporation Number of shares
  BeginsEndsCurrencyPrice for grantCurrencyExercise priceCurrencyPrice on assignment 
           
 
29. Further information in relation to interests of children under 18 and/or spouse:
Child/SpouseName of child/spouseNumber of shares
 
 
30. Further information in relation to interests of corporations controlled by Director:
Name of controlled corporationAddress and place of incorporationName of controlling person% controlDirect interest (Y/N)Number of shares
Pharmaron Holdings LimitedIntertrust Corporate Services (Cayman) Limited, 190 Elgin Avenue, George Town, Grand Cayman KY1-9005, Cayman IslandsLou Boliang67.19Y
Long position136,048,900
 
31. Further information in relation to interests held by Director jointly with another person:
Name of joint shareholderAddressNumber of shares
Lou XiaoliangAddresses of individuals are not displayed.
Long position82,500,000
Zheng BeiAddresses of individuals are not displayed.
Long position50,691,042
 
32. Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust:
Names of TrustAddressStatus codeNumber of shares
  
 
33. Further information from a party to an agreement under Section 317 (Please see Notes for further information required):
Names of other partiesAddressNumber of shares
 
Total number of shares in which a director is interested under sections 317 and 318
 
34. Supplementary information: Box 24: Please see Box 27 for capacity. Box 27/Code 2501: Lou Boliang, Lou Xiaoqiang and Zheng Bei entered into a voting rights agreement on Oct 19, 2018, pursuant to which the three are concert parties and are deemed to be interested in each other's interests in the company. Please see the company's announcement dated August 6, 2022 for further details.
35. Log/Serial Number of the previous form:
36. Number of concert party document(s) under section 317 attached/uploaded:
Date of filing this Form 3A: 04/11/2022
(dd/mm/yyyy)